Can Ganciclovir be Replaced with Valganciclovir as a Preemptive Therapy for Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantu (HSCT) Recipients?

被引：0
|
作者：
Sachdev, M. [1 ]
Chakraborty, S. [1 ]
Bansal, M. [1 ]
Dua, V. [1 ]
机构：
[1] Fortis Mem Res Inst, Pediat Hematol Oncol Bmt, Gurugram, India
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O0149
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] Oral Valganciclovir As Preemptive Therapy for Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Ozkocaman, Vildan
    Ozkalemkas, Fahir
    Ali, Ridvan
    Karacan, Yasemin
    Ersal, Tuba
    Gozden, Hilmi Erdem
    Erus, Tugcan
    Kazak, Esra
    Akalin, Halis
    BLOOD, 2014, 124 (21)
  • [2] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Katsuto Takenaka
    Tetsuya Eto
    Koji Nagafuji
    Kenjiro Kamezaki
    Yayoi Matsuo
    Goichi Yoshimoto
    Naoki Harada
    Maki Yoshida
    Hideho Henzan
    Ken Takase
    Toshihiro Miyamoto
    Koichi Akashi
    Mine Harada
    Takanori Teshima
    International Journal of Hematology, 2009, 89 : 231 - 237
  • [3] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Takenaka, Katsuto
    Eto, Tetsuya
    Nagafuji, Koji
    Kamezaki, Kenjiro
    Matsuo, Yayoi
    Yoshimoto, Goichi
    Harada, Naoki
    Yoshida, Maki
    Henzan, Hideho
    Takase, Ken
    Miyamoto, Toshihiro
    Akashi, Koichi
    Harada, Mine
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 231 - 237
  • [4] Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Takenaka, Katsuto
    Nagafuji, Koji
    Takase, Ken
    Kamimura, Tomohiko
    Mori, Yasuo
    Ito, Yoshikiyo
    Nishi, Yukiko
    Henzan, Hideho
    Kato, Koji
    Harada, Naoki
    Eto, Tetsuya
    Miyamoto, Toshihiro
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (01) : 94 - 100
  • [5] Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Katsuto Takenaka
    Koji Nagafuji
    Ken Takase
    Tomohiko Kamimura
    Yasuo Mori
    Yoshikiyo Ito
    Yukiko Nishi
    Hideho Henzan
    Koji Kato
    Naoki Harada
    Tetsuya Eto
    Toshihiro Miyamoto
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2012, 96 : 94 - 100
  • [6] A Randomized trial of preemptive therapy with ganciclovir for cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation.
    Park, J
    Lee, M
    Choi, HJ
    Park, SH
    Kim, JH
    Kim, HY
    Lee, SH
    Park, JO
    Kim, K
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Park, K
    BLOOD, 2003, 102 (11) : 442B - 442B
  • [7] Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients
    Palladino, Mariangela
    Laurenti, Luca
    Chiusolo, Patrizia
    Piccioni, Paola
    Innocenti, Idanna
    Tarnani, Michela
    Sora, Federica
    Sica, Simona
    Leone, Giuseppe
    ACTA HAEMATOLOGICA, 2010, 123 (04) : 230 - 234
  • [8] Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Barkam, Corinna
    Kamal, Haytham
    Dammann, Elke
    Diedrich, Helmut
    Buchholz, Stefanie
    Eder, Matthias
    Krauter, Juergen
    Ganser, Arnold
    Stadler, Michael
    BONE MARROW RESEARCH, 2012,
  • [9] Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation
    Busca, A.
    de Fabritiis, P.
    Ghisetti, V.
    Allice, T.
    Mirabile, M.
    Gentile, G.
    Locatelli, F.
    Falda, M.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 102 - 107
  • [10] Oral Valganciclovir as Preemptive Therapy for Cytomegalovirus Reactivation in Pediatric Hematopoietic Stem Cell Transplant Patients
    Atay, Didem
    Erbey, Fatih
    Akcay, Arzu
    Dag, Aylin
    Ozturk, Gulyuz
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (07) : 543 - 547
12345